Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (53)
Nirupama Singh, Julie Staves, Jill R. Storry, Jason Dinoso, Camille Renard, Parul Doshi, Lisa D.S. Johnson, Connie M. Westhoff & Michael F. Murphy. (2023)
Transfusion management in the era of magrolimab (
Hu5F9‐G4
), an anti‐
CD47
monoclonal antibody therapy
. Transfusion 63:12, pages 2377-2383.
Crossref
Crossref
Chao Wang, Ying Feng, Deepali Patel, Hongwei Xie, Yaqing Lv & Hai Zhao. (2023) The role of CD47 in non-neoplastic diseases. Heliyon 9:12, pages e22905.
Crossref
Crossref
Ekta Pardhi, Rati Yadav, Akash Chaurasiya, Jitender Madan, Santosh Kumar Guru, Shashi Bala Singh & Neelesh Kumar Mehra. (2023) Multifunctional targetable liposomal drug delivery system in the management of leukemia: Potential, opportunities, and emerging strategies. Life Sciences 325, pages 121771.
Crossref
Crossref
Wenxi Xia, Neetu Singh, Shreya Goel & Sixiang Shi. (2023) Molecular imaging of innate immunity and immunotherapy. Advanced Drug Delivery Reviews 198, pages 114865.
Crossref
Crossref
Mary J van Helden, Seline A Zwarthoff, Roel J Arends, Inge M J Reinieren-Beeren, Marc C B C Paradé, Lilian Driessen-Engels, Karin de Laat-Arts, Désirée Damming, Ellen W H Santegoeds-Lenssen, Daphne W J van Kuppeveld, Imke Lodewijks, Hugo Olsman, Hanke L Matlung, Katka Franke, Ellen Mattaar-Hepp, Marloes E M Stokman, Benny de Wit, Dirk H R F Glaudemans, Daniëlle E J W van Wijk, Lonnie Joosten-Stoffels, Jan Schouten, Paul J Boersema, Monique van der Vleuten, Jorien W H Sanderink, Wendela A Kappers, Diels van den Dobbelsteen, Marco Timmers, Ruud Ubink, Gerard J A Rouwendal, Gijs Verheijden, Miranda M C van der Lee, Wim H A Dokter & Timo K van den Berg. (2023) BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells. Journal for ImmunoTherapy of Cancer 11:4, pages e006567.
Crossref
Crossref
Zhongjie Tang, Xiaoyou Wang, Mei Tang, Jin Wu, Jiexuan Zhang, Xinlong Liu, Feiyan Gao, Yu Fu, Peng Tang & Chong Li. (2023) Overcoming the On‐Target Toxicity in Antibody‐Mediated Therapies via an Indirect Active Targeting Strategy. Advanced Science 10:9, pages 2206912.
Crossref
Crossref
Li Gao, Zhe He & Yonggui Wu. (2022) Advances in Anti-metabolic Disease Treatments Targeting CD47. Current Pharmaceutical Design 28:46, pages 3720-3728.
Crossref
Crossref
Hanieh Safari, Michael L. Felder, Nicholas Kaczorowski & Omolola Eniola-Adefeso. (2022) Effect of the Emulsion Solvent Evaporation Technique Cosolvent Choice on the Loading Efficiency and Release Profile of Anti-CD47 from PLGA Nanospheres. Journal of Pharmaceutical Sciences 111:9, pages 2525-2530.
Crossref
Crossref
Minwook Shin, Io Long Chan, Yuming Cao, Alisha M Gruntman, Jonathan Lee, Jacquelyn Sousa, Tomás C Rodríguez, Dimas Echeverria, Gitali Devi, Alexandre J Debacker, Michael P Moazami, Pranathi Meda Krishnamurthy, Julia M Rembetsy-Brown, Karen Kelly, Onur Yukselen, Elisa Donnard, Teagan J Parsons, Anastasia Khvorova, Erik J Sontheimer, René Maehr, Manuel Garber & Jonathan K Watts. (2022) Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts. Nucleic Acids Research 50:15, pages 8418-8430.
Crossref
Crossref
Oleg Kruglov, Lisa D. S. Johnson, Angela Minic, Kimberly Jordan, Robert A. Uger, Mark Wong, Eric L. Sievers, Yaping Shou & Oleg E. Akilov. (2021) The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides. Cancer Immunology, Immunotherapy 71:4, pages 919-932.
Crossref
Crossref
Yiyin Zhang, Zhengze Huang, Jiaxi Cheng, Haoqi Pan, Tianyu Lin, Xuqiu Shen, Wenchao Chen, Qi Chen, Chenhui Gu, Qijiang Mao & Yuelong Liang. (2022) Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress. Frontiers in Endocrinology 13.
Crossref
Crossref
Brittany Ann Ruschkowski, Yousef Esmaeil, Kate Daniel, Chantal Gaudet, Behzad Yeganeh, David Grynspan & Robert P. Jankov. (2022) Thrombospondin-1 Plays a Major Pathogenic Role in Experimental and Human Bronchopulmonary Dysplasia. American Journal of Respiratory and Critical Care Medicine 205:6, pages 685-699.
Crossref
Crossref
Katie-May McLaughlin, Denisa Bojkova, Joshua D. Kandler, Marco Bechtel, Philipp Reus, Trang Le, Florian Rothweiler, Julian U. G. Wagner, Andreas Weigert, Sandra Ciesek, Mark N. Wass, Martin Michaelis & Jindrich CinatlJr.Jr.. (2021) A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis. Current Issues in Molecular Biology 43:3, pages 1212-1225.
Crossref
Crossref
Zahra Beizavi, Seyed Mohammad Gheibihayat, Hadis Moghadasian, Hossein Zare, Babak Shirazi Yeganeh, Hassan Askari, Sina Vakili, Amir Tajbakhsh & Amir Savardashtaki. (2021) The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?. Molecular Biology Reports 48:7, pages 5707-5722.
Crossref
Crossref
Xiao-Jing Ye, Jian-Guang Yang, Ya-Qin Tan, Xiao-Jie Chen & Gang Zhou. (2021) Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma. Anti-Cancer Agents in Medicinal Chemistry 21:6, pages 766-774.
Crossref
Crossref
Xihui Gao, Sha Li, Fei Ding, Xinlong Liu, Yijing Wu, Jing Li, Jing Feng, Xinyuan Zhu & Chuan Zhang. (2021) A Virus‐Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy. Advanced Materials 33:9, pages 2006116.
Crossref
Crossref
Jiaying Yang, Yongjun Yao, Li Tong, Ziwei Zhu, Lei Wang & Jinju Yang. (2021) CD47 is highly expressed in gliomas and targeting CD47 is a promising therapeutic strategy. European Journal of Inflammation 19, pages 205873922110008.
Crossref
Crossref
Heather Norman-Burgdolf, Dong Li, Patrick Sullivan & Shuxia Wang. (2020) CD47 differentially regulates white and brown fat function. Biology Open 9:12.
Crossref
Crossref
Shuyan Wang, Yaou Duan, Qiangzhe Zhang, Anvita Komarla, Hua Gong, Weiwei Gao & Liangfang Zhang. (2020) Drug Targeting via Platelet Membrane–Coated Nanoparticles. Small Structures 1:1, pages 2000018.
Crossref
Crossref
Jing Zhang, Su-Bee Tan & Zhi-Gang Guo. (2020) CD47 decline in pancreatic islet cells promotes macrophage-mediated phagocytosis in type I diabetes. World Journal of Diabetes 11:6, pages 239-251.
Crossref
Crossref
Quanli Cheng, Junlian Gu, Binay Kumar Adhikari, Liguang Sun & Jian Sun. (2020) Is CD47 a potentially promising therapeutic target in cardiovascular diseases? — Role of CD47 in cardiovascular diseases. Life Sciences 247, pages 117426.
Crossref
Crossref
Yao Huang, Sai‐qun Lv, Pin‐yi Liu, Zhen‐long Ye, Huan Yang, Lin‐fang Li, Hai‐li Zhu, Ying Wang, Lian‐zhen Cui, Du‐qing Jiang, Fang‐yuan Hao, Hui‐min Xu, Hua‐jun Jin & Qi‐jun Qian. (2020) A SIRPα‐Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer. Molecular Oncology 14:3, pages 657-668.
Crossref
Crossref
Maryam El‐Rashid, Kedar Ghimire, Barkha Sanganeria, Bo Lu & and Natasha M. Rogers. (2019) CD47 limits autophagy to promote acute kidney injury. The FASEB Journal 33:11, pages 12735-12749.
Crossref
Crossref
Elodie PramilLinda Herbi BastianThomas Denèfle, Fariba NematiMalina XiaoEva LardéKarim Maloum, Damien Roos-Weil, Elise Chapiro, Magali Le Garff-Tavernier, Frédéric DaviDidier DecaudinMarika Sarfati, Florence Nguyen-Khac, Hélène Merle-Béral, Philippe Karoyan & Santos A. Susin. (2019) Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance. Blood Advances 3:20, pages 2920-2933.
Crossref
Crossref
Elizabeth R. Stirling, Katherine L. Cook, David D. Roberts & David R. Soto-Pantoja. (2019) Metabolomic Analysis Reveals Unique Biochemical Signatures Associated with Protection from Radiation Induced Lung Injury by Lack of cd47 Receptor Gene Expression. Metabolites 9:10, pages 218.
Crossref
Crossref
Thomas Denèfle, Elodie Pramil, Luis Gómez-Morales, Mikail D. Levasseur, Eva Lardé, Clara Newton, Kenny Herry, Linda Herbi, Yann Lamotte, Estelle Odile, Nicolas Ancellin, Pascal Grondin, Ana-Carolina Martinez-Torres, Fabrice Viviani, Hélène Merle-Beral, Olivier Lequin, Santos A. Susin & Philippe Karoyan. (2019) Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells. Journal of Medicinal Chemistry 62:17, pages 7656-7668.
Crossref
Crossref
Lisa D. S. Johnson, Swati Banerjee, Oleg KruglovNatasja Nielsen VillerSteven M. HorwitzAlexander LesokhinJasmine ZainChristiane QuerfeldRobert ChenCraig Okada, Ahmed Sawas, Owen A. O’Connor, Eric L. SieversYaping ShouRobert A. UgerMark WongOleg E. Akilov. (2019) Targeting CD47 in Sézary syndrome with SIRPαFc. Blood Advances 3:7, pages 1145-1153.
Crossref
Crossref
Katherine L. Cook. 2019. The Unfolded Protein Response in Cancer. The Unfolded Protein Response in Cancer
181
195
.
Yismeilin R. Feliz-Mosquea, Ashley A. Christensen, Adam S. Wilson, Brian Westwood, Jasmina Varagic, Giselle C. Meléndez, Anthony L. Schwartz, Qing-Rong Chen, Lesley Mathews Griner, Rajarshi Guha, Craig J. Thomas, Marc Ferrer, Maria J. Merino, Katherine L. Cook, David D. Roberts & David R. Soto-Pantoja. (2018) Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. Breast Cancer Research and Treatment 172:1, pages 69-82.
Crossref
Crossref
Jianfeng Guo, Xue Luan, Zhongcheng Cong, Yao Sun, Limei Wang, Sharon L. McKenna, Mary R. Cahill & Caitriona M. O'Driscoll. (2018) The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia. Journal of Controlled Release 286, pages 154-166.
Crossref
Crossref
Ankita Solanki, Lokesh Kumar Bhatt & Thomas P. Johnston. (2018) Evolving targets for the treatment of atherosclerosis. Pharmacology & Therapeutics 187, pages 1-12.
Crossref
Crossref
Chen Zhao, Jeffrey S. Isenberg & Aleksander S. Popel. (2018) Human expression patterns: qualitative and quantitative analysis of thrombospondin‐1 under physiological and pathological conditions. Journal of Cellular and Molecular Medicine 22:4, pages 2086-2097.
Crossref
Crossref
David R. Soto-Pantoja, Adam S. Wilson, Kenysha YJ. Clear, Brian Westwood, Pierre L. Triozzi & Katherine L. Cook. (2017) Unfolded protein response signaling impacts macrophage polarity to modulate breast cancer cell clearance and melanoma immune checkpoint therapy responsiveness. Oncotarget 8:46, pages 80545-80559.
Crossref
Crossref
Tomoya Sudo, Yusuke Takahashi, Genta Sawada, Ryutaro Uchi, Koshi Mimori & Yoshito Akagi. (2017) Significance of CD47 expression in gastric cancer. Oncology Letters 14:1, pages 801-809.
Crossref
Crossref
Dalia Martinez-Marin, Courtney Jarvis, Thomas Nelius, Werner de Riese, Olga V. Volpert & Stéphanie Filleur. (2017) PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro. PLOS ONE 12:4, pages e0174968.
Crossref
Crossref
Lu Gao, Kexin Chen, Qi Gao, Xiaodan Wang, Jian Sun & Yong-Guang Yang. (2016) CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis. Oncotarget 8:14, pages 22406-22413.
Crossref
Crossref
E C Pietsch, J Dong, R Cardoso, X Zhang, D Chin, R Hawkins, T Dinh, M Zhou, B Strake, P-H Feng, M Rocca, C Dos Santos, X Shan, G Danet-Desnoyers, F Shi, E Kaiser, H J Millar, S Fenton, R Swanson, J A Nemeth & R M Attar. (2017) Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies. Blood Cancer Journal 7:2, pages e536-e536.
Crossref
Crossref
Hui Li, Yan Wang & Yan-Zhong Li. (2016) MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47. Tumor Biology 37:12, pages 16103-16113.
Crossref
Crossref
Irina Sokolova, Marina Gafarova, Maria Khokhlova, Alexei Muravyev, Evgeny Lyubin, Maria Skryabina, Andrey Fedyanin, Tatiana Krasnova & Alexandr Shahnazarov. (2016) Glycoprotein IIB-IIIA inhibitor, monafram decelerate the early phase of red blood cells aggregation. Journal of Cellular Biotechnology 2:1, pages 15-22.
Crossref
Crossref
Zhenyu Xiao, Babak Banan, Min Xu, Jianluo Jia, Pamela T. Manning, Ronald R. Hiebsch, Muthukumar Gunasekaran, Gundumi A. Upadhya, William A. Frazier, Thalachallour Mohanakumar, Yiing Lin & William C. Chapman. (2016) Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody. Transplantation 100:7, pages 1480-1489.
Crossref
Crossref
Qiangguo Gao, Yi Zhang, Chaofeng Han, Xiang Hu, Hua Zhang, Xiongfei Xu, Jun Tian, Yiqi Liu, Yuanyuan Ding, Juan Liu, Chunmei Wang, Zhenhong Guo, Yongguang Yang & Xuetao Cao. (2016) Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells. Journal of Autoimmunity 69, pages 74-85.
Crossref
Crossref
Nathan E.K. Procter, Jocasta Ball, Doan T.M. Ngo, Yuliy Y. Chirkov, Jeffrey S. Isenberg, Elaine M. Hylek, Simon Stewart & John D. Horowitz. (2015) Platelet hyperaggregability in patients with atrial fibrillationThrombozytenhyperaggregabilität bei Patienten mit Vorhofflimmern. Herz 41:1, pages 57-62.
Crossref
Crossref
Maura L. Gillison & Carlo Restighini. (2015) Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient. Hematology/Oncology Clinics of North America 29:6, pages 1045-1060.
Crossref
Crossref
Albin Jeanne, Christophe Schneider, Laurent Martiny & Stéphane Dedieu. (2015) Original insights on thrombospondin-1-related antireceptor strategies in cancer. Frontiers in Pharmacology 6.
Crossref
Crossref
Dhammika H. M. L. P. Navarathna, Erica V. Stein, Elizabeth C. Lessey-Morillon, Debasis Nayak, Gema Martin-Manso & David D. Roberts. (2015) CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis. PLOS ONE 10:5, pages e0128220.
Crossref
Crossref
Ana-Carolina Martinez-Torres, Claire Quiney, Tarik Attout, Heloïse Boullet, Linda Herbi, Laura Vela, Sandrine Barbier, Danielle Chateau, Elise Chapiro, Florence Nguyen-Khac, Frédéric Davi, Magali Le Garff-Tavernier, Roba Moumné, Marika Sarfati, Philippe Karoyan, Hélène Merle-Béral, Pierre Launay & Santos A. Susin. (2015) CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans. PLOS Medicine 12:3, pages e1001796.
Crossref
Crossref
Shlomo Rotshenker. 2015. Nerves and Nerve Injuries. Nerves and Nerve Injuries
611
628
.
Peter L. Choyke. (2014) Nanoparticles: Take Only Pictures, Leave Only Footprints. Science Translational Medicine 6:260.
Crossref
Crossref
David R. Soto-Pantoja, Hubert B. Shih, Justin B. Maxhimer, Katherine L. Cook, Arunima Ghosh, Jeffrey S. Isenberg & David D. Roberts. (2014) Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice. Matrix Biology 37, pages 25-34.
Crossref
Crossref
A. Neil BarclayTimo K. van den Berg. (2014) The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target. Annual Review of Immunology 32:1, pages 25-50.
Crossref
Crossref
Natasha M. Rogers, Mingyi Yao, John Sembrat, M. Patricia George, Heather Knupp, Mark Ross, Maryam Sharifi‐Sanjani, Jadranka Milosevic, Claudette St. Croix, Revathi Rajkumar, Maria C. Frid, Kendall S. Hunter, Luciano Mazzaro, Enrico M. Novelli, Kurt R. Stenmark, Mark T. Gladwin, Ferhaan Ahmad, Hunter C. Champion & Jeffrey S. Isenberg. (2013) Cellular, Pharmacological, and Biophysical Evaluation of Explanted Lungs from a Patient with Sickle Cell Disease and Severe Pulmonary Arterial Hypertension. Pulmonary Circulation 3:4, pages 936-951.
Crossref
Crossref
Thomas W. Miller, Sukhbir Kaur, Kelly Ivins-O'Keefe & David D. Roberts. (2013) Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation. Matrix Biology 32:6, pages 316-324.
Crossref
Crossref
Alicia Sawdon & Ching-An Peng. (2013) Engineering antiphagocytic biomimetic drug carriers. Therapeutic Delivery 4:7, pages 825-839.
Crossref
Crossref